How many institutions held CMND - Clearmind Medicine Inc. - Common Shares, no par value per share in Q2 2025?

7 institutional investors reported CMND - Clearmind Medicine Inc. - Common Shares, no par value per share for Q2 2025. Use the holders table for investor-level position and value details.

Clearmind Medicine Inc. - Common Shares, no par value per share (CMND)

Q: What does CUSIP 185053402 represent in this 13F holders report?

CUSIP 185053402 is the security identifier for CMND - Clearmind Medicine Inc. - Common Shares, no par value per share used to aggregate holder disclosures.

CUSIP: 185053402

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class: Equity / Common Shares, no par value per share
Shares outstanding: 2,174,400
Total 13F shares: 244,330
Share change: -13,449
Total reported value: $216,133
Price per share: $0.88
Number of holders: 7
Value change: -$13,983
Number of buys: 3
Number of sells: 2

Quarterly Holders Quick Answers

What is CUSIP 185053402?
CUSIP 185053402 identifies CMND - Clearmind Medicine Inc. - Common Shares, no par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2025
Previous quarter: Q1 2025

Recent filing periods for CUSIP 185053402:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of CMND - Clearmind Medicine Inc. - Common Shares, no par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Gotham Asset Management, LLC	13F	Company	16%	343,427	$5,185,747	—	31 Mar 2025	13F
AdvisorShares Investments LLC	13F	Company	10%	220,933	$227,561	—	31 Mar 2025	13F
AdvisorShares Trust	13D/G	—	4.8%	205,933	$177,102	$0	30 Jun 2025	13D/G
Cornerstone Wealth Group, LLC	13F	Company	0.92%	20,000	$20,700	—	31 Mar 2025	13F
TWO SIGMA SECURITIES, LLC	13F	Company	0.64%	13,903	$14,390	—	31 Mar 2025	13F
MORGAN STANLEY	13F	Company	0.12%	2,564	$2,654	—	31 Mar 2025	13F
ROYAL BANK OF CANADA	13F	Company	0.03%	569	$1,000	—	31 Mar 2025	13F
NATIONAL BANK OF CANADA /FI/	13F	Company	0.02%	379	$390	—	31 Mar 2025	13F

Institutional Holders of Clearmind Medicine Inc. - Common Shares, no par value per share (CMND) as of Q2 2025

As of 30 Jun 2025, Clearmind Medicine Inc. - Common Shares, no par value per share (CMND) was held by 7 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 244,330 shares. The largest 7 holders included AdvisorShares Investments LLC, Cornerstone Wealth Group, LLC, XTX Topco Ltd, JPMORGAN CHASE & CO, MORGAN STANLEY, OSAIC HOLDINGS, INC., and NATIONAL BANK OF CANADA /FI/. This page lists 7 institutional shareholders reporting positions in this security for the Q2 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders

Q2 2025 holders

Holder diff

Investor	Q1 2025 Shares	Q2 2025 Shares	Share Diff	Share Chg %	Q1 2025 Value $	Q2 2025 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.